Fibrinogen and prothrombin complex concentrate in trauma coagulopathy

BackgroundCoagulopathy after injury contributes to hemorrhage and death. Treatment with specific coagulation factors could decrease hemorrhage and mortality. Our aim was to compare fibrinogen and prothrombin complex concentrate (PCC) in a rabbit model of hemorrhagic shock.Materials and methodsNew Zealand white rabbits were anesthetized. Blood was withdrawn to a mean arterial pressure (MAP) of 30–40 mm Hg for 30 min. Animals were resuscitated with lactated Ringer to a MAP of 50–60 mm Hg and randomized to receive 100 mg/kg of fibrinogen, PCC 25 IU/kg, or lactated Ringer. A liver injury was created. A MAP of 50–60 mm Hg was maintained for 60 min. The primary outcome was blood loss, and secondary outcomes were fluid administered and coagulopathy as measured by plasma-based tests.ResultsThere were eight animals in each group. Median blood loss was significantly higher in the fibrinogen group, at 122 mL (95% confidence interval [CI], 75–194), when compared with that in the control group, 35 mL (95% CI, 23–46; P value = 0.001), and the PCC group, 26 mL (95% CI, 4–54; P value = 0.002). Resuscitation fluid requirement was highest in the fibrinogen group, at 374 mL (95% CI, 274–519), and lowest in the PCC group, at 238 mL (95% CI, 212–309) (P = 0.01). Plasma-based coagulation tests were not different among groups.ConclusionsIn a rabbit model, PCC did not have a significant effect on blood loss. Fibrinogen increased blood loss and fluid requirements.